Skip to main content
CODX
NASDAQ Life Sciences

Co-Diagnostics JV Initiates Clinical Studies for TB Test in India, Deploying PCR Platform

Tom Rudovsky · Reported by PR Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.526
Mkt Cap
$12.458M
52W Low
$1.26
52W High
$46.5
52W Position info
100% above low
Off High info
95% below high
Rel. Volume
Market data snapshot near publication time

CODX has more than doubled off its 52-week low of $1.26.

Summary

Co-Diagnostics' Indian joint venture CoSara has started clinical studies for a tuberculosis test on its PCR Pro platform, with instruments and kits now deployed to select labs across India. This is a concrete step toward commercialization in a country with one of the world's highest TB burdens. The move follows earlier shipments of instruments and kits, and comes as the company faces a going concern warning and has been raising capital through deeply discounted offerings. Successful clinical data could open a significant revenue stream and validate the platform in a key market, but regulatory approval and commercial uptake remain uncertain. The company's cash position is precarious, so any path to revenue is critical.

At the time of this announcement, CODX was trading at $2.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.5M. The 52-week trading range was $1.26 to $46.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CODX - Latest Insights

CODX
Nov 04, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.3615
Real-time Price: $0.2856 info
Change: -$0.0759 (-21%) info
Market Cap: $2.357M info
CODX
Oct 26, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.5459
Real-time Price: $0.2856 info
Change: -$0.2603 (-48%) info
Market Cap: $2.357M info
CODX
Oct 19, 2026, 12:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.6726
Real-time Price: $0.2856 info
Change: -$0.387 (-58%) info
Market Cap: $2.357M info
CODX
Oct 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7201
Real-time Price: $0.2856 info
Change: -$0.4345 (-60%) info
Market Cap: $2.357M info
CODX
Oct 13, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.23
Real-time Price: $0.2856 info
Change: -$0.9444 (-77%) info
Market Cap: $2.357M info